| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
|---|
| 06/09/1999 | CN1219174A Inhibitors of protein farnesyl transferase |
| 06/09/1999 | CN1218802A Substituted isoquinoline-3-formamides compounds, its preparing method and its use as medicine |
| 06/08/1999 | US5910609 Compounds |
| 06/08/1999 | US5910565 Oligoglycine compound, fibrous microtube of oligoglycine compound and process of producing fibrous microtube |
| 06/08/1999 | US5910404 Amino acid sequence of peptide mimetic; for screening blood and blood products; use as immunogens |
| 06/08/1999 | CA2089972C Sulfonamidocarboxamides |
| 06/08/1999 | CA1340588C Amino acid derivatives |
| 06/03/1999 | WO1999026964A1 LIQUID PHASE PROCESS FOR THE PREPARATION OF GnRH PEPTIDES |
| 06/03/1999 | WO1999026963A1 Hypusine peptides |
| 06/03/1999 | WO1999026926A1 Heteroaryl aminoguanidines and alkoxyguanidines and their use as protease inhibitors |
| 06/03/1999 | WO1999026922A1 Substituted pyrrole derivatives as cell adhesion inhibitors |
| 06/03/1999 | WO1999007729A3 Peptides having potassium channel opener activity |
| 06/03/1999 | CA2311969A1 Heteroaryl aminoguanidines and alkoxyguanidines and their use as protease inhibitors |
| 06/03/1999 | CA2310027A1 Hypusine peptides |
| 06/02/1999 | EP0919567A1 Novel peptides and nootropic agent |
| 06/02/1999 | EP0918792A1 Dipeptide benzamidine as a kininogenase inhibitor |
| 06/02/1999 | EP0918547A2 Radiolabeled annexins |
| 06/02/1999 | EP0918534A1 Peptidyl prodrugs and methods of making and using the same |
| 06/02/1999 | EP0680513B1 Lysosomal targeting of immunogens |
| 06/02/1999 | EP0667854B1 Peptidyl activated ketone inhibitors containing natural and unnatural peptide sequences |
| 06/02/1999 | CN1218454A Preparation of 1-alkoxycarbonyl-3-phenylpropyl derivatives |
| 06/02/1999 | CN1218047A Novel imidazolidine derivatives, their preparation, their use and pharmaceutical preparations comprising them |
| 06/01/1999 | US5908919 Drug delivery |
| 06/01/1999 | US5908843 Thrombosis, antiinflammatory agent, arteriosclerosis, antitumor agents |
| 06/01/1999 | CA1340570C Process for synthesizing n-alkylated amino-acides and the esters thereof. their use for synthesizing carboxyalkyl dipeptides |
| 06/01/1999 | CA1340566C Process for crystallizing l-a-aspartyl-l-phenylalanine methyl ester |
| 05/27/1999 | WO1999025690A2 Advanced glycation end-product intermediaries and post-amadori inhibition |
| 05/27/1999 | WO1999025381A1 Linear antigen supporting units |
| 05/27/1999 | WO1999025372A1 Small peptides and methods for treatment of asthma and inflammation |
| 05/27/1999 | WO1999010371A3 Cyclopeptide derivatives as adhesion inhibitors |
| 05/27/1999 | CA2310462A1 Linear antigen supporting units |
| 05/27/1999 | CA2310233A1 Advanced glycation end-product intermediaries and post-amadori inhibition |
| 05/26/1999 | EP0918059A1 Substituted imidazoline derivatives, their preparation, their use, and pharmaceutical compositions containing them |
| 05/26/1999 | EP0918054A1 A 1/2 sulfate of a ((S)-1-((S)-2-((trans-4-aminocyclohexylmethyl) carbamoyl) pyrrolidine-1-carbonyl)-2-iso-propylthio-2-methylpropyl) carbamic acid propyl ester |
| 05/26/1999 | EP0917462A1 Cell adhesion inhibitors |
| 05/26/1999 | EP0833835A4 Obesity protein intermediates and their preparation and use |
| 05/26/1999 | EP0811012B1 Method of producing l-aspartyl-d-alanine-n-(thiethane-3-yl)-amides |
| 05/26/1999 | EP0804459A4 Therapeutic compound - fatty acid conjugates |
| 05/26/1999 | EP0783316A4 Synthetic antibiotics |
| 05/26/1999 | EP0589993B1 Human p450 iid6 cytochrome-derived peptide fragments, anti peptide fragment antibodies, and applications thereof in the diagnosis of autoimmune hepatitis |
| 05/26/1999 | CN1217334A Phosphoric-acid substituted benzo-aza-tropone-N-acetic acid derivative, preparing method and medicine thereof |
| 05/26/1999 | CN1217327A D-proline derivative |
| 05/25/1999 | US5907068 Peptide derivatives |
| 05/25/1999 | US5907044 Solvent extraction, crystallization |
| 05/25/1999 | US5907043 Coupling n-(4-methoxybenzoyl)-l-valyl-l-proline or a salt with 3-amino-4-methyl-1,1,1-trifluoro-2-pentanol forming (s)-1-(s)-2-(4-methoxybenzamido)-3-(2,2,2-trifluoro-1-hydroxy ethyl)propyl)pyrrolidine-2-carboxamide, oxidizing the product |
| 05/25/1999 | US5906922 Delivery of nucleic acids |
| 05/20/1999 | WO1999024553A2 X-ray crystal comprising hiv-1 gp120 |
| 05/20/1999 | WO1999024461A1 Clostridial toxin inhibitors and pharmaceutical compositions containing same |
| 05/20/1999 | WO1999024460A2 Dipeptide nitriles |
| 05/20/1999 | WO1999024442A1 Novel signal transduction inhibitors, compositions containing them |
| 05/20/1999 | WO1999024398A2 Urea derivatives and their use as integrin inhibitors |
| 05/20/1999 | WO1999009977A8 1,2,5-thiadiazolidin-3-one 1,1-dioxide derivatives |
| 05/20/1999 | WO1999007733A3 Hepatitis c inhibitor peptides |
| 05/20/1999 | WO1998024806B1 Substituted oxadiazole, thiadiazole and triazole serine protease inhibitors |
| 05/20/1999 | WO1998013007A8 Methods and compositions for lipidization of hydrophilic molecules |
| 05/20/1999 | CA2309792A1 Novel signal transduction inhibitors, compositions containing them |
| 05/20/1999 | CA2308716A1 Urea derivatives and their use as integrin inhibitors |
| 05/19/1999 | EP0916679A1 Benzazepinone-N-acetic acid derivatives having a phosphonic acid group, process for their preparation and medicaments containing these compounds |
| 05/19/1999 | EP0916396A2 Combinatorial strategies for polymer synthesis |
| 05/19/1999 | EP0915700A1 Use of beta-sheet mimetics as protease and kinase inhibitors and as inhibitors of transcription factors |
| 05/19/1999 | EP0726936B1 Liquid detergents with ortho-substituted phenylboronic acids for inhibition of proteolytic enzyme |
| 05/19/1999 | CN1216767A Novel 5-membered ring heterocycles, their prepn. their use and pharmaceutical preparations comprising them |
| 05/18/1999 | US5905149 Substituted quinolymethylen-oxindole analogues as tyrosine kinase inhibitors |
| 05/18/1999 | US5905077 Inhibitors of HIV protease useful for the treatment of AIDS |
| 05/18/1999 | US5905076 Treatment of muscular dystrophy, arthritis, myocardial infarction, alzheimer's disease, bacterial infection, common cold, osteoporosis or cancer metastasis |
| 05/18/1999 | US5905071 Glycosylamides of 2-aminoacylamino-2-deoxy sugars |
| 05/14/1999 | WO1999023064A1 2-(r)-fluorosulfonyloxy-4-phenylbutiric acid esters, production process and process for its utilization in the preparation of carboxyalkyldipeptides |
| 05/14/1999 | WO1999022758A1 Tri-, tetra-, penta-, and polypeptides and their therapeutic use as an antidepressant agent |
| 05/14/1999 | WO1998051697A3 Method for producing polymers having nucleo-bases as side-groups |
| 05/14/1999 | WO1998014593A9 Human telomerase catalytic subunit |
| 05/12/1999 | EP0915088A1 D-Proline derivatives |
| 05/12/1999 | EP0914827A1 Ophthalmic drug compositions |
| 05/12/1999 | EP0914605A1 Molecular model for vla-4 inhibitors |
| 05/12/1999 | EP0914342A2 Derivatives of somatostatin, amino acids or oligopeptides and their combination useful for promoting body growth |
| 05/12/1999 | EP0914334A1 Process and intermediates for the synthesis of lhrh antagonists |
| 05/12/1999 | EP0914332A1 Isoquinolines useful as analgesics |
| 05/12/1999 | EP0914331A1 Neuroactive peptides |
| 05/12/1999 | EP0914123A1 Prodrugs of thalidomide and methods for using same as modulators of t-cell function |
| 05/12/1999 | CN1216537A Compounds with growth hormone releasing properties |
| 05/11/1999 | US5902790 Pharmaceutical angiostatic dipeptide compositions and method of use thereof |
| 05/11/1999 | US5902737 Process for the preparation of disodium benzyloxycarbonyl-L-aspartate from fumaric acid |
| 05/06/1999 | WO1999021877A1 Histogranin peptide and their analgesic use |
| 05/06/1999 | WO1999021876A1 Novel aspartame crystals and process for the preparation thereof |
| 05/06/1999 | WO1999021571A1 Melanocortin receptor ligands and methods of using same |
| 05/06/1999 | EP0912758A1 Compositions and methods for screening antimicrobials |
| 05/06/1999 | EP0912602A1 Method of treating beta-amyloid peptide associated conditions using trh |
| 05/06/1999 | EP0912601A1 Suppression of immune response via inhibition of cathepsin s |
| 05/06/1999 | EP0912600A2 Peptidomimetic inhibitors of cathepsin d and plasmepsins i and ii |
| 05/06/1999 | EP0688315B1 Pyrrolidine and oxazolidine derivatives, their preparation and their use as inhibitors of thrombocyte aggregation |
| 05/06/1999 | CA2306754A1 Histogranin peptide and their analgesic use |
| 05/05/1999 | CN1215995A Reactor and method for solid phase peptide synthesis |
| 05/04/1999 | US5900427 N-heteroarenesulfonyl-protected amino acid reagents for peptide synthesis |
| 05/04/1999 | US5900413 Administering with amoxicillin |
| 04/29/1999 | WO1999021015A2 Affinity ligands, their production and use |
| 04/29/1999 | WO1999020648A1 Process for the purification of aspartame derivative |
| 04/29/1999 | WO1999005165A8 Streptogramines, their preparation and compositions containing them |
| 04/29/1999 | CA2301688A1 Process for the purification of aspartame derivative |
| 04/28/1999 | EP0911340A2 Substituted Isoquinolin-3-Carboxyamides, their preparation and medical use |
| 04/28/1999 | EP0911327A1 Novel pyridonecarboxylic acid derivatives or their salts and antibacterial agent comprising the same as the active ingredient |
| 04/28/1999 | EP0910583A1 Thrombin inhibitors |